AG

Artal Group Portfolio holdings

AUM $715M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
-28.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.38B
AUM Growth
+$336M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
124
New
Increased
Reduced
Closed

Top Buys

1 +$25.1M
2 +$10.5M
3 +$8.99M
4
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$7.86M
5
ALBO
Albireo Pharma Inc
ALBO
+$7.61M

Top Sells

1 +$33.5M
2 +$17.4M
3 +$11.1M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$10.2M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$9.07M

Sector Composition

1 Consumer Staples 53.33%
2 Consumer Discretionary 24.25%
3 Healthcare 21.69%
4 Financials 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
1
$2.87B 53.33%
87,460,875
2
$1.3B 24.25%
29,443,300
3
$576M 10.71%
58,274,650
+756,673
4
$57.2M 1.06%
450,000
+200,000
5
$47.4M 0.88%
500,000
+100,000
6
$31.8M 0.59%
750,000
+50,000
7
$29.3M 0.55%
300,000
+75,000
8
$28.6M 0.53%
500,000
+50,000
9
$26.7M 0.5%
11,580
+1,158
10
$23.9M 0.44%
26,667
-56,666
11
$19.4M 0.36%
250,000
-150,000
12
$19.2M 0.36%
1,500,000
13
$18.1M 0.34%
40,000
+16,000
14
$16.6M 0.31%
150,000
+30,000
15
$15.1M 0.28%
150,000
16
$14.4M 0.27%
1,000,000
+300,000
17
$13.8M 0.26%
350,000
+50,000
18
$13.1M 0.24%
50,000
+30,000
19
$12.7M 0.24%
400,000
+150,000
20
$12.6M 0.23%
200,000
+145,663
21
$12.4M 0.23%
75,000
-75,000
22
$8.31M 0.15%
250,000
+90,000
23
$8.29M 0.15%
100,000
+25,000
24
$8.15M 0.15%
127,388
+13
25
$7.82M 0.15%
+500,000